HomePCSA • NASDAQ
add
Processa Pharmaceuticals Inc
Previous close
$2.33
Day range
$2.30 - $2.45
Year range
$1.76 - $19.63
Market cap
6.12M USD
Avg Volume
37.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.70M | 35.37% |
Net income | -3.36M | -23.10% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.70M | -35.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.54M | 364.77% |
Total assets | 7.81M | 141.96% |
Total liabilities | 2.24M | 45.86% |
Total equity | 5.58M | — |
Shares outstanding | 2.66M | — |
Price to book | 1.07 | — |
Return on assets | -120.21% | — |
Return on capital | -162.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.36M | -23.10% |
Cash from operations | -2.90M | -29.05% |
Cash from investing | -850.00K | — |
Cash from financing | 2.98M | 444.05% |
Net change in cash | -771.46K | 54.62% |
Free cash flow | -2.42M | -5,400.68% |
About
Founded
2011
Headquarters
Website
Employees
12
